Kim SR, Hong JH, Kim SG, Kim SK, et al. Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial. Diabetes Obes Metab 2026 Feb 3. doi: 10.1111/dom.70527.
PMID: 41630635